Formulation, manufacturing and regulatory strategies for extracellular vesicles-based drug products for targeted therapy of central nervous system diseases

References

• Spinelli C, Adnani L, Choi D, et al. Extracellular vesicles as conduits of non-coding RNA emission and intercellular transfer in brain tumors. Noncoding RNA. 2018;5(1):1.
   Web of Science ®Google Scholar
• Valadi H, Ekström K, Bossios A, et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007 Jun 01;9(6):654–659.
   PubMed Web of Science ®Google Scholar
• Yáñez-Mó M, Siljander PRM, Andreu Z, et al. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles. 2015 Jan 01;4(1):27066.
   PubMed Web of Science ®Google Scholar
• Epple LM, Griffiths SG, Dechkovskaia AM, et al. Medulloblastoma exosome proteomics yield functional roles for extracellular vesicles. Plos One. 2012;7(7):e42064.
   PubMed Web of Science ®Google Scholar
• Babatunde KA, Yesodha Subramanian B, Ahouidi AD, et al. Role of extracellular vesicles in cellular cross talk in malaria [Review]. Front Immunol. 2020 Jan 31;11(22). DOI:10.3389/fimmu.2020.00022
   PubMedGoogle Scholar
• Mathews PM, Levy E. Exosome production is key to neuronal endosomal pathway integrity in neurodegenerative diseases [Review]. Front Neurosci. 2019 Dec 12;13(1347). DOI:10.3389/fnins.2019.01347
   PubMedGoogle Scholar
• Kalani MYS, Alsop E, Meechoovet B, et al. Extracellular microRNAs in blood differentiate between ischaemic and haemorrhagic stroke subtypes. J Extracell Vesicles. 2020 Jan 01;9(1):1713540.
   PubMed Web of Science ®Google Scholar
• McMillan HJ, Darras BT, Kang PB. Autoimmune neuromuscular disorders in childhood. Curr Treat Options Neurol. 2011 Sep 13;13(6):590.
   PubMed Web of Science ®Google Scholar
• Cheng Y, Pereira M, Raukar N, et al. Potential biomarkers to detect traumatic brain injury by the profiling of salivary extracellular vesicles. J Cell Physiol. 2019;234(8):14377–14388.
   PubMed Web of Science ®Google Scholar
• Jung H-Y, Lee C-H, Choi J-Y, et al. Potential urinary extracellular vesicle protein biomarkers of chronic active antibody-mediated rejection in kidney transplant recipients. J Chromatogr B. 2020 Feb 01;1138:121958.
   PubMed Web of Science ®Google Scholar
• Pisano C, Galley J, Elbahrawy M, et al. Human breast milk-derived extracellular vesicles in the protection against experimental necrotizing enterocolitis. J Pediatr Surg. 2020 Jan 01;55(1):54–58.
   PubMed Web of Science ®Google Scholar
• Ebert B, Rai AJ. Isolation and characterization of amniotic fluid-derived extracellular vesicles for biomarker discovery. Methods Mol Biol. 2019; 1885:287–294.
   Google Scholar
• Lässer C, Théry C, Buzás EI, et al. The international society for extracellular vesicles launches the first massive open online course on extracellular vesicles. J Extracell Vesicles. 2016 Jan 01;5(1):34299.
   PubMed Web of Science ®Google Scholar
• György B, Szabó TG, Pásztói M, et al. Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol Life Sci. 2011 Aug 01;68(16):2667–2688.
   PubMed Web of Science ®Google Scholar
• Willms E, Johansson HJ, Mäger I, et al. Cells release subpopulations of exosomes with distinct molecular and biological properties. Sci Rep. 2016 Mar 02;6(1):22519.
   PubMedGoogle Scholar
• Willms E, Cabañas C, Mäger I, et al. Extracellular vesicle heterogeneity: subpopulations, isolation techniques, and diverse functions in cancer progression [Review]. Front Immunol. 2018 Apr 30;9(738). DOI:10.3389/fimmu.2018.00738
   PubMedGoogle Scholar
• Sun R, Wang H, Shi Y, et al. Changes in the morphology, number, and pathological protein levels of plasma exosomes may help diagnose alzheimer’s disease. J Alzheimers Dis. 2020;73(3):909–917.
   PubMed Web of Science ®Google Scholar
• Goetzl EJ, Yaffe K, Peltz CB, et al. Traumatic brain injury increases plasma astrocyte-derived exosome levels of neurotoxic complement proteins. Faseb J. 2020;34(2):3359–3366.
   PubMed Web of Science ®Google Scholar
• Mondello S, Thelin EP, Shaw G, et al. Extracellular vesicles: pathogenetic, diagnostic and therapeutic value in traumatic brain injury. Expert Rev Proteomics. 2018 May 04;15(5):451–461.
   PubMed Web of Science ®Google Scholar
• Hill AF. Extracellular vesicles and neurodegenerative diseases. J Neurosci. 2019;39(47):9269–9273.
   PubMed Web of Science ®Google Scholar
• Kapogiannis D, Mustapic M, Shardell MD, et al. Association of extracellular vesicle biomarkers with Alzheimer disease in the baltimore longitudinal study of aging. JAMA Neurol. 2019;76(11):1340–1351.
   PubMed Web of Science ®Google Scholar
• Candelario KM, Balaj L, Zheng T, et al. Exosome/microvesicle content is altered in leucine-rich repeat kinase 2 mutant induced pluripotent stem cell-derived neural cells. J Comp Neurol. 2020;528(7):1203–1215.
   PubMed Web of Science ®Google Scholar
• Willis CM, Nicaise AM, Menoret A, et al. Extracellular vesicle fibrinogen induces encephalitogenic CD8+ T cells in a mouse model of multiple sclerosis. Proc Nat Acad Sci. 2019;116(21):10488–10493.
   PubMed Web of Science ®Google Scholar
• Sáenz-Cuesta M, Alberro A, Muñoz-Culla M, et al. The first dose of fingolimod affects circulating extracellular vesicles in multiple sclerosis patients. Int J Mol Sci. 2018;19(8):2448.
   Web of Science ®Google Scholar
• Otero-Ortega L, Laso-García F, Frutos MCG-D, et al. Low dose of extracellular vesicles identified that promote recovery after ischemic stroke. Stem Cell Res Ther. 2020 Feb 19;11(1):70.
   PubMed Web of Science ®Google Scholar
• Yuxia H, Don S, Yuling M, et al. Multipotent mesenchymal stromal cell–derived exosomes improve functional recovery after experimental intracerebral hemorrhage in the rat. J Neurosurg. 2018;131(1):290–300.
   PubMed Web of Science ®Google Scholar
• Huang S, Ge X, Yu J, et al. Increased miR-124-3p in microglial exosomes following traumatic brain injury inhibits neuronal inflammation and contributes to neurite outgrowth via their transfer into neurons. Faseb J. 2018;32(1):512–528.
   PubMed Web of Science ®Google Scholar
• Eggers C, Arendt G, Hahn K, et al. HIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment. J Neurol. 2017 Aug 01;264(8):1715–1727.
   PubMed Web of Science ®Google Scholar
• Guha D, Lorenz DR, Misra V, et al. Proteomic analysis of cerebrospinal fluid extracellular vesicles reveals synaptic injury, inflammation, and stress response markers in HIV patients with cognitive impairment. J Neuroinflammation. 2019 Dec 05;16(1):254.
   PubMed Web of Science ®Google Scholar
• Tabernero J, Shapiro GI, LoRusso PM, et al. First-in-humans trial of an RNA interference therapeutic targeting VEGF and KSP in cancer patients with liver involvement. Cancer Discov. 2013;3(4):406–417.
   PubMed Web of Science ®Google Scholar
• Swaminathan M, Stafford-Smith M, Chertow GM, et al. Allogeneic mesenchymal stem cells for treatment of AKI after cardiac surgery. J Am Soc Nephrol. 2018 Jan;29(1):260–267.
   PubMed Web of Science ®Google Scholar
• Geeurickx E, Tulkens J, Dhondt B, et al. The generation and use of recombinant extracellular vesicles as biological reference material. Nat Commun. 2019 Jul 23;10(1):3288.
   PubMedGoogle Scholar
• Szatanek R, Baran J, Siedlar M, et al. Isolation of extracellular vesicles: determining the correct approach (Review). Int J Mol Med. 2015 Jul;36(1):11–17. DOI:10.3892/ijmm.2015.2194
   PubMed Web of Science ®Google Scholar
• Au - DeMarino C, Au - Barclay RA, Au - Pleet ML, et al. Purification of high yield extracellular vesicle preparations away from virus. J Vis Exp. 2019 Sep 12;(151):10.3791/59876.Published 2019 Sep 12. DOI:10.3791/59876
   Google Scholar
• Guideline IHT. Preclinical safety evaluation of biotechnology-derived pharmaceuticals s6 (r1).
   Google Scholar
• Lener T, Gimona M, Aigner L, et al. Applying extracellular vesicles based therapeutics in clinical trials – an ISEV position paper. J Extracell Vesicles. 2015 Jan 01;4(1):30087.
   PubMed Web of Science ®Google Scholar
• Hegmans JPJJ, Bard MPL, Hemmes A, et al. Proteomic analysis of exosomes secreted by human mesothelioma cells. Am J Pathol. 2004;164(5):1807–1815.
   PubMed Web of Science ®Google Scholar
• Welton JL, Khanna S, Giles PJ, et al. Proteomics analysis of bladder cancer exosomes. Mol Cell Proteomics. 2010;9(6):1324–1338.
   PubMed Web of Science ®Google Scholar
• Wubbolts R, Leckie RS, Veenhuizen PT, et al. Proteomic and biochemical analyses of human B cell-derived exosomes. Potential implications for their function and multivesicular body formation. Journal Biol Chem. 2003 Mar 28;278(13):10963–10972.
   PubMed Web of Science ®Google Scholar
• Choi DS, Kim DK, Kim YK, et al. Proteomics of extracellular vesicles: exosomes and ectosomes. Mass Spectrom Rev. 2015 Jul-Aug;34(4):474–490.
   PubMed Web of Science ®Google Scholar
• Bandu R, Oh JW, Kim KP. Mass spectrometry-based proteome profiling of extracellular vesicles and their roles in cancer biology. Exp Mol Med. 2019;51(3):1–10.
   PubMedGoogle Scholar
• Thery C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol. 2002 Aug;2(8):569–579.
   PubMed Web of Science ®Google Scholar
• Munagala R, Aqil F, Jeyabalan J, et al. Bovine milk-derived exosomes for drug delivery. Cancer Lett. 2016 Feb 1;371(1):48–61.
   PubMed Web of Science ®Google Scholar
• Yamashita T, Takahashi Y, Nishikawa M, et al. Effect of exosome isolation methods on physicochemical properties of exosomes and clearance of exosomes from the blood circulation. Eur J Pharm Biopharm. 2016 Jan;98:1–8.
   PubMed Web of Science ®Google Scholar
• Charoenviriyakul C, Takahashi Y, Morishita M, et al. Cell type-specific and common characteristics of exosomes derived from mouse cell lines: yield, physicochemical properties, and pharmacokinetics. Eur J Pharm Sci. 2017 Jan 1;96:316–322.
   PubMed Web of Science ®Google Scholar
• Hong Y, Nam G-H, Koh E, et al. Exosome as a vehicle for delivery of membrane protein therapeutics, PH20, for enhanced tumor penetration and antitumor efficacy. Adv Funct Mater. 2018;28(5):1801301.
   Web of Science ®Google Scholar
• Lamparski HG, Metha-Damani A, Yao J-Y, et al. Production and characterization of clinical grade exosomes derived from dendritic cells. J Immunol Methods. 2002 Dec 15;270(2):211–226.
   PubMed Web of Science ®Google Scholar
• Alvarez ML, Khosroheidari M, Kanchi Ravi R, et al. Comparison of protein, microRNA, and mRNA yields using different methods of urinary exosome isolation for the discovery of kidney disease biomarkers. Kidney Int. 2012;82(9):1024–1032.
   PubMed Web of Science ®Google Scholar
• Ueda K, Ishikawa N, Tatsuguchi A, et al. Antibody-coupled monolithic silica microtips for highthroughput molecular profiling of circulating exosomes. Sci Rep. 2015;4(1):6232.
   Google Scholar
• Nakai W, Yoshida T, Diez D, et al. A novel affinity-based method for the isolation of highly purified extracellular vesicles. Sci Rep. 2016;6(1):33935.
   PubMedGoogle Scholar
• Koga K, Matsumoto K, Akiyoshi T, et al. Purification, characterization and biological significance of tumor-derived exosomes. Anticancer Res. 2005 Nov 1;25(6A):3703–3707.
   PubMed Web of Science ®Google Scholar
• Qazi KR, Gehrmann U, Domange Jordö E, et al. Antigen-loaded exosomes alone induce Th1-type memory through a B cell–dependent mechanism. Blood. 2009;113(12):2673–2683.
   PubMed Web of Science ®Google Scholar
• Ohno S, Takanashi M, Sudo K, et al. Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells. Mol Ther. 2013 Jan;21(1):185–191.
   PubMed Web of Science ®Google Scholar
• Huang L, Gu N, Zhang X-E, et al. Light-inducible exosome-based vehicle for endogenous RNA loading and delivery to leukemia cells. Adv Funct Mater. 2019;29(9):1807189.
   Web of Science ®Google Scholar
• Pomatto MAC, Bussolati B, D’Antico S, et al. Improved loading of plasma-derived extracellular vesicles to encapsulate antitumor miRNAs. Mol Ther Methods Clin Dev. 2019 Jun;14(13):133–144.
   Google Scholar
• Serrano-Pertierra E, Oliveira-Rodríguez M, Rivas M, et al. Characterization of plasma-derived extracellular vesicles isolated by different methods: a comparison study. Bioengineering. 2019;6(1):8.
   Google Scholar
• Dragovic RA, Gardiner C, Brooks AS, et al. Sizing and phenotyping of cellular vesicles using nanoparticle tracking analysis. Nanomed Nanotechnol biol Med. 2011 Dec 01;7(6):780–788.
   PubMed Web of Science ®Google Scholar
• Soo CY, Song Y, Zheng Y, et al. Nanoparticle tracking analysis monitors microvesicle and exosome secretion from immune cells. Immunology. 2012;136(2):192–197.
   PubMed Web of Science ®Google Scholar
• De Toro J, Herschlik L, Waldner C, et al. Emerging roles of exosomes in normal and pathological conditions: new insights for diagnosis and therapeutic applications. Front Immunol. 2015;6:203.
   PubMed Web of Science ®Google Scholar
• Serrano-Pertierra E, Oliveira-Rodriguez M, Rivas M, et al. Characterization of plasma-derived extracellular vesicles isolated by different methods: a comparison study. Bioengineering (Basel). 2019 Jan 17;6(1). DOI:10.3390/bioengineering6020029
   Google Scholar
• Stoner SA, Duggan E, Condello D, et al. High sensitivity flow cytometry of membrane vesicles. Cytometry Part A. 2016 Feb 01;89(2):196–206.
   PubMed Web of Science ®Google Scholar
• Morales-Kastresana A, Telford B, Musich TA, et al. Labeling extracellular vesicles for nanoscale flow cytometry. Sci Rep. 2017 May 12;7(1):1878.
   PubMed Web of Science ®Google Scholar
• Jeong S, Park J, Pathania D, et al. Integrated magneto–electrochemical sensor for exosome analysis. ACS Nano. 2016;10(2):1802–1809.
   PubMed Web of Science ®Google Scholar
• Xu H, Liao C, Zuo P, et al. Magnetic-based microfluidic device for on-chip isolation and detection of tumor-derived exosomes. Anal Chem. 2018;90(22):13451–13458.
   PubMed Web of Science ®Google Scholar
• Vogel R, Willmott G, Kozak D, et al. Quantitative sizing of nano/microparticles with a tunable elastomeric pore sensor. Anal Chem. 2011;83(9):3499–3506.
   PubMed Web of Science ®Google Scholar
• Im H, Shao H, Park YI, et al. Label-free detection and molecular profiling of exosomes with a nano-plasmonic sensor. Nat Biotechnol. 2014;32(5):490–495.
   PubMed Web of Science ®Google Scholar
• Zhu L, Wang K, Cui J, et al. Label-free quantitative detection of tumor-derived exosomes through surface plasmon resonance imaging. Anal Chem. 2014;86(17):8857–8864.
   PubMed Web of Science ®Google Scholar
• Wang Q, Zou L, Yang X, et al. Direct quantification of cancerous exosomes via surface plasmon resonance with dual gold nanoparticle-assisted signal amplification. Biosens Bioelectron. 2019 Jun 15;135:129–136.
   PubMed Web of Science ®Google Scholar
• Vázquez-Ríos AJ, Molina-Crespo Á, Bouzo BL, et al. Exosome-mimetic nanoplatforms for targeted cancer drug delivery. J Nanobiotechnology. 2019 Jul 18;17(1):85.
   PubMed Web of Science ®Google Scholar
• Sun D, Zhuang X, Grizzle W, et al. Abstract 4446: A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. Cancer Res. 2011;71(8 Supplement):4446.
   Google Scholar
• Sun D, Zhuang X, Xiang X, et al. A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. Mol Ther. 2010 Sep 01;18(9):1606–1614.
   PubMed Web of Science ®Google Scholar
• Jang SC, Kim OY, Yoon CM, et al. Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors. ACS Nano. 2013 Sep 24;7(9):7698–7710.
   PubMed Web of Science ®Google Scholar
• Kim MS, Haney MJ, Zhao Y, et al. Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells. Nanomed Nanotechnol Biol Med. 2016 Apr 01;12(3):655–664.
   PubMed Web of Science ®Google Scholar
• Saari H, Lázaro-Ibáñez E, Viitala T, et al. Microvesicle- and exosome-mediated drug delivery enhances the cytotoxicity of Paclitaxel in autologous prostate cancer cells. J Control Release. 2015 Dec 28;220:727–737.
   PubMed Web of Science ®Google Scholar
• Yang T, Martin P, Fogarty B, et al. Exosome delivered anticancer drugs across the blood-brain barrier for brain cancer therapy in danio rerio. Pharm Res. 2015 Jun 01;32(6):2003–2014.
   PubMed Web of Science ®Google Scholar
• Ying M, Zhuang J, Wei X, et al. Remote-loaded platelet vesicles for disease-targeted delivery of therapeutics. Adv Funct Mater. 2018;28(22):1801032.
   PubMed Web of Science ®Google Scholar
• Hatzidaki E, Vlachou I, Elka A, et al. The use of serum extracellular vesicles for novel small molecule inhibitor cell delivery. Anticancer Drugs. 2019;30(3):271–280.
   PubMed Web of Science ®Google Scholar
• Yang X, Shi G, Guo J, et al. Exosome-encapsulated antibiotic against intracellular infections of methicillin-resistant Staphylococcus aureus. Int J Nanomedicine. 2018;13:8095–8104.
   PubMed Web of Science ®Google Scholar
• Aqil F, Kausar H, Agrawal AK, et al. Exosomal formulation enhances therapeutic response of celastrol against lung cancer. Exp Mol Pathol. 2016 Aug 01;101(1):12–21.
   PubMed Web of Science ®Google Scholar
• Didiot M-C, Hall LM, Coles AH, et al. Exosome-mediated delivery of hydrophobically modified siRNA for Huntingtin mRNA silencing. Mol Ther. 2016 Oct 01;24(10):1836–1847.
   PubMed Web of Science ®Google Scholar
• Haraszti RA, Miller R, Didiot M-C, et al. Optimized cholesterol-siRNA chemistry improves productive loading onto extracellular vesicles. Mol Ther. 2018 Aug 01;26(8):1973–1982.
   PubMed Web of Science ®Google Scholar
• Shtam TA, Kovalev RA, Varfolomeeva EY, et al. Exosomes are natural carriers of exogenous siRNA to human cells in vitro. Cell Commun Signaling. 2013 Nov 18;11(1):88.
   PubMed Web of Science ®Google Scholar
• Malhotra H, Sheokand N, Kumar S, et al. Exosomes: tunable nano vehicles for macromolecular delivery of transferrin and lactoferrin to specific intracellular compartment. J Biomed Nanotechnol. 2016;12(5):1101–1114.
   PubMed Web of Science ®Google Scholar
• Haney MJ, Klyachko NL, Zhao Y, et al. Exosomes as drug delivery vehicles for Parkinson’s disease therapy. J Control Release. 2015 Jun 10;207:18–30.
   PubMed Web of Science ®Google Scholar
• Nakase I, Futaki S. Combined treatment with a pH-sensitive fusogenic peptide and cationic lipids achieves enhanced cytosolic delivery of exosomes. Sci Rep. 2015 May 26;5(1):10112.
   PubMedGoogle Scholar
• Lamichhane TN, Jeyaram A, Patel DB, et al. Oncogene knockdown via active loading of small RNAs into extracellular vesicles by sonication. Cell Mol Bioeng. 2016 Sep 01;9(3):315–324.
   PubMed Web of Science ®Google Scholar
• Zhi K. Formulation and fabrication of a novel subcutaneous implant for the zero-order release of selected protein and small molecule drugs. Temple University Libraries; 2017.
   Google Scholar
• Momen-Heravi F, Bala S, Bukong T, et al. Exosome-mediated delivery of functionally active miRNA-155 inhibitor to macrophages. Nanomedicine. 2014 Oct 01;10(7):1517–1527.
   PubMed Web of Science ®Google Scholar
• Hadla M, Palazzolo S, Corona G, et al. Exosomes increase the therapeutic index of doxorubicin in breast and ovarian cancer mouse models. Nanomedicine. 2016 Sep 01;11(18):2431–2441.
   PubMed Web of Science ®Google Scholar
• Toffoli G, Hadla M, Corona G, et al. Exosomal doxorubicin reduces the cardiac toxicity of doxorubicin. Nanomedicine. 2015 Oct 01;10(19):2963–2971.
   PubMed Web of Science ®Google Scholar
• Tian Y, Li S, Song J, et al. A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. Biomaterials. 2014 Feb 01;35(7):2383–2390.
   PubMed Web of Science ®Google Scholar
• Greco KA, Franzen CA, Foreman KE, et al. PLK-1 silencing in bladder cancer by siRNA delivered with exosomes. Urology. 2016 May 01;91:241.e1-e7.
   PubMed Web of Science ®Google Scholar
• Lunavat TR, Jang SC, Nilsson L, et al. RNAi delivery by exosome-mimetic nanovesicles – implications for targeting c-Myc in cancer. Biomaterials. 2016 Sep 01;102:231–238.
   PubMed Web of Science ®Google Scholar
• Lamichhane TN, Raiker RS, Jay SM. Exogenous DNA loading into extracellular vesicles via electroporation is size-dependent and enables limited gene delivery. Mol Pharm. 2015 Oct 05;12(10):3650–3657.
   PubMed Web of Science ®Google Scholar
• Kooijmans SAA, Stremersch S, Braeckmans K, et al. Electroporation-induced siRNA precipitation obscures the efficiency of siRNA loading into extracellular vesicles. J Control Release. 2013 Nov 28;172(1):229–238.
   PubMed Web of Science ®Google Scholar
• Sato YT, Umezaki K, Sawada S, et al. Engineering hybrid exosomes by membrane fusion with liposomes. Sci Rep. 2016 Feb 25;6(1):21933.
   PubMed Web of Science ®Google Scholar
• Fuhrmann G, Serio A, Mazo M, et al. Active loading into extracellular vesicles significantly improves the cellular uptake and photodynamic effect of porphyrins. J Control Release. 2015 May 10;205:35–44.
   PubMed Web of Science ®Google Scholar
• Pascucci L, Coccè V, Bonomi A, et al. Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: A new approach for drug delivery. J Control Release. 2014 Oct 28;192:262–270.
   PubMed Web of Science ®Google Scholar
• Aspe JR, Diaz Osterman CJ, Jutzy JMS, et al. Enhancement of Gemcitabine sensitivity in pancreatic adenocarcinoma by novel exosome-mediated delivery of the Survivin-T34A mutant. J Extracell Vesicles. 2014 Jan 01;3(1):23244.
   PubMedGoogle Scholar
• Katakowski M, Buller B, Zheng X, et al. Exosomes from marrow stromal cells expressing miR-146b inhibit glioma growth. Cancer Lett. 2013 Jul 10;335(1):201–204.
   PubMed Web of Science ®Google Scholar
• Lin Y, Wu J, Gu W, et al. Exosome–Liposome Hybrid Nanoparticles Deliver CRISPR/Cas9 System in MSCs. Adv Sci. 2018;5(4):1700611.
   Web of Science ®Google Scholar
• Yim N, Ryu S-W, Choi K, et al. Exosome engineering for efficient intracellular delivery of soluble proteins using optically reversible protein–protein interaction module. Nat Commun. 2016 Jul 22;7(1):12277.
   PubMedGoogle Scholar
• O’Brien K, Lowry MC, Corcoran C, et al. miR-134 in extracellular vesicles reduces triple-negative breast cancer aggression and increases drug sensitivity. Oncotarget. 2015;6(32):32774–32789.
   PubMed Web of Science ®Google Scholar
• Lou G, Song X, Yang F, et al. Exosomes derived from miR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinoma. J Hematol Oncol. 2015 Oct 29;8(1):122.
   PubMedGoogle Scholar
• Shimbo K, Miyaki S, Ishitobi H, et al. Exosome-formed synthetic microRNA-143 is transferred to osteosarcoma cells and inhibits their migration. Biochem Biophys Res Commun. 2014 Mar 07;445(2):381–387.
   PubMed Web of Science ®Google Scholar
• Cooper JM, Wiklander PBO, Nordin JZ, et al. Systemic exosomal siRNA delivery reduced alpha-synuclein aggregates in brains of transgenic mice. Mov Disord. 2014 Oct 01;29(12):1476–1485.
   PubMed Web of Science ®Google Scholar
• Umezu T, Ohyashiki K, Kuroda M, et al. Leukemia cell to endothelial cell communication via exosomal miRNAs. Oncogene. 2013 May 01;32(22):2747–2755.
   PubMed Web of Science ®Google Scholar
• King HW, Michael MZ, Gleadle JM. Hypoxic enhancement of exosome release by breast cancer cells. BMC Cancer. 2012 Sep 24;12(1):421.
   PubMed Web of Science ®Google Scholar
• Alvarez-Erviti L, Seow Y, Yin H, et al. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol. 2011 Apr 01;29(4):341–345. DOI:10.1038/nbt.1807
   PubMed Web of Science ®Google Scholar
• Jarlais DCD, Friedman SR. AIDS and legal access to sterile drug injection equipment. ANNALS Am Acad Political Social Sci. 1992;521(1):42–65.
   Google Scholar
• FDA. Guidance for industry: sterile drug products produced by aseptic processing — current good manufacturing practice; 2004. Available from: www.fda.gov,editor
   Google Scholar
• EMA. Guideline on the sterilisation of the medicinal product, active substance, excipient and primary container; 2019.
   Google Scholar
• Stkwart DC, Hawthorne D, Evans DE. Cold sterile filtration: a small scale filtration test and investigation of membrane plugging. J Inst Brewing. 1998;104(6):321–326.
   Web of Science ®Google Scholar
• Wahlgren J, Karlson TDL, Brisslert M, et al. Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytes. Nucleic Acids Res. 2012;40(17):e130–e130.
   PubMed Web of Science ®Google Scholar
• Zhang D, Lee H, Zhu Z, et al. Enrichment of selective miRNAs in exosomes and delivery of exosomal miRNAs in vitro and in vivo. Am J Physiol Lung Cell Mol Physiol. 2017;312(1):L110–L121.
   PubMed Web of Science ®Google Scholar
• Kooijmans SA, Gitz-Francois JJ, Schiffelers RM, et al. Recombinant phosphatidylserine-binding nanobodies for targeting of extracellular vesicles to tumor cells: a plug-and-play approach. Nanoscale. 2018;10(5):2413–2426.
   PubMed Web of Science ®Google Scholar
• CDC. Steam sterilization: guideline for disinfection and sterilization in healthcare facilities (2008); 2008. Available from: https://www.cdc.gov/infectioncontrol/guidelines/disinfection/sterilization/steam.html
   Google Scholar
• Schulz E, Karagianni A, Koch M, et al. Hot EVs – how temperature affects extracellular vesicles. Eur J Pharm Biopharm. 2020 Jan 01;146:55–63.
   PubMed Web of Science ®Google Scholar
• Escudier B, Dorval T, Chaput N, et al. Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial. J Transl Med. 2005 Mar 02;3(1):10.
   PubMed Web of Science ®Google Scholar
• Navabi H, Croston D, Hobot J, et al. Preparation of human ovarian cancer ascites-derived exosomes for a clinical trial. Blood Cell Mol Dis. 2005 Sep 01;35(2):149–152.
   PubMed Web of Science ®Google Scholar
• Dai S, Wei D, Wu Z, et al. Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer. Mol Ther. 2008 Apr 01;16(4):782–790.
   PubMed Web of Science ®Google Scholar
• Morse MA, Garst J, Osada T, et al. A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer. J Transl Med. 2005 Feb 21;3(1):9.
   PubMed Web of Science ®Google Scholar
• Andriolo G, Provasi E, Lo Cicero V, et al. Exosomes from human cardiac progenitor cells for therapeutic applications: development of a GMP-grade manufacturing method [Methods]. Front Physiol. 2018 Aug 24;9(1169). DOI:10.3389/fphys.2018.01169
   PubMedGoogle Scholar
• Gimona M, Pachler K, Laner-Plamberger S, et al. Manufacturing of human extracellular vesicle-based therapeutics for clinical use. Int J Mol Sci. 2017;18(6):1190.
   PubMed Web of Science ®Google Scholar
• Gong Y, Chowdhury P, Nagesh PKB, et al. Novel elvitegravir nanoformulation for drug delivery across the blood-brain barrier to achieve HIV-1 suppression in the CNS macrophages. Sci Rep. 2020 Mar 02;10(1):3835.
   PubMed Web of Science ®Google Scholar
• Gong Y, Zhi K, Nagesh PKB, et al. An elvitegravir nanoformulation crosses the blood–brain barrier and suppresses hiv-1 replication in microglia. Viruses. 2020;12(5):564.
   Web of Science ®Google Scholar
• Sterzenbach U, Putz U, Low L-H, et al. Engineered exosomes as vehicles for biologically active proteins. Mol Ther. 2017 Jun 07;25(6):1269–1278.
   PubMed Web of Science ®Google Scholar
• Zhuang X, Xiang X, Grizzle W, et al. Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. Mol Ther. 2011 Oct 01;19(10):1769–1779.
   PubMed Web of Science ®Google Scholar
• Kumar S, Zhi K, Mukherji A, et al. Repurposing antiviral protease inhibitors using extracellular vesicles for potential therapy of COVID-19. Viruses. 2020;12(5):486.
   PubMed Web of Science ®Google Scholar
• Liberti L, Breckenridge A, Hoekman J, et al. Accelerating access to new medicines: current status of facilitated regulatory pathways used by emerging regulatory authorities. J Public Health Policy. 2016 Aug 01;37(3):315–333.
   PubMed Web of Science ®Google Scholar
• Liberti L, Breckenridge A, Hoekman J, et al., editors. Practical aspects of developing, implementing and using facilitated regulatory pathways in the emerging markets. Poster Drug Information Association Annual Meeting, Philadelphia, PA. 2016 Jun. DOI:10.13140/RG.2.2.31518.28486/1
   Google Scholar